Schonfeld Strategic Advisors’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
Schonfeld Strategic Advisors's SRDX Position: Q4 2025 in Review
Schonfeld Strategic Advisors sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 99,984 shares — an estimated $2.99M sold.
Schonfeld Strategic Advisors first reported a position in SRDX in Q4 2018 and held it in 5 quarters. The position peaked at $4.42M in Q2 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Schonfeld Strategic Advisors reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 99,984 Surmodics shares in Q4 2025, an estimated $2.99M.
- Schonfeld Strategic Advisors first reported a position in Surmodics in Q4 2018 and held it in 5 quarters.
- Schonfeld Strategic Advisors's Surmodics position peaked at $4.42M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.